Definium Therapeutics Income Statement (2020-2026) | DFTX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
0.03B0.03B0.03B0.05B0.07B0.08B0.08B0.08B0.08B0.08B0.10B0.10B
Operating items
Research & Development (Quarter)
0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.03B0.03B0.03B0.04B
Selling, General & Administrative (Quarter)
0.04B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B
Operating Expenses (Quarter)
0.05B0.02B0.02B0.02B0.02B0.02B0.01B0.02B0.03B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.04B0.05B0.05B0.06B
Operating Income (Quarter)
-0.05B-0.02B-0.02B-0.02B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.04B-0.05B-0.05B-0.06B
EBIT (Quarter)
-0.05B-0.02B-0.02B-0.02B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.04B-0.05B-0.05B-0.06B
Non-operating items
Non Operating Investment Income (Quarter)
0.00B0.00B0.00B0.00B-0.00B
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.03B0.00B0.01B-0.00B-0.00B-0.00B-0.00B-0.02B
Net income details
EBT (Quarter)
-0.05B-0.02B0.03B-0.03B-0.02B-0.02B-0.00B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-2.57B-0.04B-0.05B-58.21B
Tax Provisions (Quarter)
-0.02B0.00B
Profit After Tax (Quarter)
-0.04B-0.02B-0.02B-0.02B-0.02B-0.02B-0.00B-0.02B-0.03B-0.02B-0.02B-0.05B-0.01B-0.01B-0.03B-0.02B-0.04B-0.07B-0.05B-0.08B
Income from Continuing Operations (Quarter)
-0.05B-0.02B0.05B-0.03B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-2.57B-0.04B-0.05B-58.21B
Consolidated Net Income (Quarter)
-0.05B-0.02B0.05B-0.03B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-2.57B-0.04B-0.05B-58.21B
Income towards Parent Company (Quarter)
-0.05B-0.02B0.05B-0.03B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-2.57B-0.04B-0.05B-58.21B
Net Income towards Common Stockholders (Quarter)
-0.05B-0.02B0.05B-0.03B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.05B-0.01B-0.01B-0.03B-0.02B-0.04B-0.07B-0.05B-0.08B
Additional items
EPS (Basic) (Quarter)
-1.65-0.611.69-0.99-0.60-0.56-0.17-0.51-0.72-0.53-0.53-1.14-0.08-0.18-0.49-0.27-0.50-0.78-0.56-0.71
EPS (Diluted) (Quarter)
-1.65-0.611.69-0.99-0.60-0.56-0.17-0.51-0.72-0.53-0.53-1.14-0.08-0.17-0.49-0.27-0.50-0.78-0.56-0.71
Shares Outstanding (Quarter)
0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.04B0.04B0.04B0.04B0.05B0.07B0.08B0.07B0.09B0.09B0.09B0.09B0.11B
Shares Outstanding (Diluted) (Quarter)
0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.04B0.04B0.04B0.04B0.05B0.08B0.08B0.07B0.09B0.09B0.09B0.09B0.11B
EBITDA (Quarter)
-0.05B-0.02B-0.02B-0.02B-0.02B-0.02B-0.01B-0.02B-0.03B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.04B-0.05B-0.05B-0.06B
Interest Expenses (Quarter)
0.00B0.01B0.04B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B2.53B0.00B0.00B58.15B
Tax Rate (Quarter)
-74.40-4.57